NCT03948438 Endoscopic Treatment for Zenker's Diverticulum
| NCT ID | NCT03948438 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Clinico Humanitas |
| Condition | Zenker Diverticulum |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2009-01-01 |
| Primary Completion | 2028-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2009-01-01 with a primary completion date of 2028-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Zenker's diverticulum (ZD) is a rare benign condition, due to an acquired sac-like outpouching of the mucosa and submucosa layers originating from the pharyngoesophageal junction. Endoscopic techniques like flexible endoscopic septum division (FESD) or per-oral endoscopic septotomy (POES), represent a minimally invasive alternative to surgery or to rigid endoscopic procedure to treat ZD. The goal of the research will be to evaluate the safety of the procedures and to measure Zenker-symptom severity in all patients treated by endoscopic procedures.
Eligibility Criteria
Inclusion Criteria: * patients with symptomatic ZD treated by endoscopic procedures Exclusion Criteria: * pregnancy and breastfeeding
Contact & Investigator
Alessandro Repici, Prof.
✉ alessandro.repici@hunimed.euFrequently Asked Questions
Who can join the NCT03948438 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Zenker Diverticulum. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03948438 currently recruiting?
Yes, NCT03948438 is actively recruiting participants. Contact the research team at alessandro.repici@hunimed.eu for enrollment information.
Where is the NCT03948438 trial being conducted?
This trial is being conducted at Rozzano, Italy.
Who is sponsoring the NCT03948438 clinical trial?
NCT03948438 is sponsored by Istituto Clinico Humanitas. The trial plans to enroll 400 participants.